Angelo Rossini
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Infection Control in Healthcare
Papers in
-
- Infection Control in Healthcare 8
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 2
-
- Antibiotic Resistance in Bacteria 11
- Co-authors
- Antonino Salvia (10 shared papers)Maria Pia Balice (5 shared papers)Carlo Caltagirone (8 shared papers)Andrea Termine (5 shared papers)Giovanna Borsellino (4 shared papers)Carlo Fabrizio (5 shared papers)Luca Battistini (4 shared papers)Mario Picozza (3 shared papers)
In The Last Decade
Angelo Rossini
37 papers receiving 904 citations
Peers
Comparison fields: 5 of 79
- Molecular Medicine 352
- Infectious Diseases 384
- Endocrinology 38
- Applied Microbiology and Biotechnology 16
- Leadership and Management 7
Countries citing papers authored by Angelo Rossini
This map shows the geographic impact of Angelo Rossini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Rossini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Rossini more than expected).
Fields of papers citing papers by Angelo Rossini
This network shows the impact of papers produced by Angelo Rossini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Rossini. The network helps show where Angelo Rossini may publish in the future.
Co-authors
The 25 scholars most cited alongside Angelo Rossini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 178 | |
| 2 | 2014 | 127 | |
| 3 | 2012 | 59 | |
| 4 | 2013 | 57 | |
| 5 | 2015 | 53 | |
| 6 | 2022 | 53 | |
| 7 | 2013 | 49 | |
| 8 | 2015 | 40 | |
| 9 | 2014 | 29 | |
| 10 | 2014 | 26 | |
| 11 | 2022 | 26 | |
| 12 | 2017 | 25 | |
| 13 | 2012 | 19 | |
| 14 | 2015 | 16 | |
| 15 | 2021 | 16 | |
| 16 | 2002 | 14 | |
| 17 | 2019 | 14 | |
| 18 | 2019 | 13 | |
| 19 | 2019 | 12 | |
| 20 | 2022 | 12 |
About Angelo Rossini
Angelo Rossini is a scholar working on Infectious Diseases, Molecular Medicine, Applied Psychology, Microbiology and Endocrinology, having authored 38 papers that have together received 923 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), Infection Control in Healthcare (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (2 papers), Digital Mental Health Interventions (2 papers), Medical Device Sterilization and Disinfection (2 papers), COVID-19 and Mental Health (2 papers) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Molecular Medicine (352 citations), Infectious Diseases (384 citations), Endocrinology (38 citations), Applied Microbiology and Biotechnology (16 citations) and Leadership and Management (7 citations). Angelo Rossini has collaborated with scholars based in Italy, Israel and Poland. Frequent co-authors include Antonino Salvia, Maria Pia Balice, Carlo Caltagirone, Andrea Termine, Giovanna Borsellino, Carlo Fabrizio, Luca Battistini, Mario Picozza, Gisella Guerrera and Silvia D’Orso. Their work appears in journals such as Clinical Microbiology and Infection, American Journal of Infection Control, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy and Journal of Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.